It was reported that restenosis occurred.The subject was enrolled in the eminent study on (b)(6) 2017 and the index procedure was performed on the same day.Target lesion was located in left mid sfa with 100% stenosis and was 50 mm long with a proximal reference vessel diameter of 5 mm and distal reference vessel diameter of 5.3 mm and was classified as tasc ii a lesion.Target lesion was treated with pre-dilation followed by placement of a 7 mm x 60 mm study stent.Following post dilation, residual stenosis was 0%.On (b)(6) 2017, the subject was discharged with antiplatelet medications.On (b)(6) 2019, 710 days post index procedure, the subject presented to the enrolling site for the protocol specified 2-year follow-up visit.Rutherford category assessed on the same day was 0 (asymptomatic).Diagnostic tests revealed 70% stenosis of the femoral artery on the left -proximal to the stent.Intervention was planned on a later date.On (b)(6) 2019, the subject was hospitalized for the planned intervention.On (b)(6) 2019, 731 days post index procedure, the 70% stenosis in left proximal and distal sfa was treated with percutaneous transluminal angioplasty (pta) and stenting resulting in 0% final stenosis.On (b)(6) 2019, the event was resolved and the subject was discharged on (b)(6) 2019.
|